Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2012

SciClone Pharmaceuticals, Inc. (SCLN) Updates 2011 Financials and Provides Initial Guidance for 2012

Posted on January 9, 2012 by MissionIR

SciClone Pharmaceuticals, Inc. is a specialty pharmaceutical company with a substantial commercial business in China. Its product portfolio, of nearly 20 drugs sold in over 30 countries, includes therapies for oncology, infectious diseases, and cardiovascular, urological, respiratory, and central nervous … Continue reading →

Posted in Small Cap News | Leave a comment

NEI (NEI) Revises Outlook for First Fiscal Quarter with Higher than Expected Revenues and Income

Posted on January 9, 2012 by MissionIR

NEI, a leading provider of server-based application platforms, deployment solutions and lifecycle support services for software technology developers and OEMs worldwide, recently announced revised and improved expectations for the first fiscal quarter period ending December 31, 2011. Net revenues are … Continue reading →

Posted in Small Cap News | Leave a comment

A123 Systems, Inc. (AONE) to Supply Battery Packs for Electric Trucks

Posted on January 6, 2012 by MissionIR

Yesterday, A123 Systems announced that they would be supplying complete lithium ion battery packs to VIA Motors for use in VIA’s eREV Powertrain vehicles. The 24kWh batteries will power both an onboard motor and generator in the trucks, and will … Continue reading →

Posted in Small Cap News | Leave a comment

ESP Resources (ESPI) Deploys 6th Fracking Unit, Updates on Increased Revenue Stream

Posted on January 6, 2012 by MissionIR

ESP Resources Inc., an oil and gas services company offering analytical services and essential custom-blended oil and gas well chemicals to improve production yields and overall efficiencies, today announced the deployment of its sixth chemical delivery fracking (hydraulic fracturing) unit … Continue reading →

Posted in Small Cap News | Leave a comment

BioDelivery Sciences (BDSI) and Endo (ENDP) Ink $180M Licensing and Development Agreement

Posted on January 6, 2012 by MissionIR

BioDelivery Sciences International, a specialty pharmaceutical company focused on developing products in the areas of pain management and oncology supportive care, today announced it has signed a $180 million agreement with Endo Pharmaceuticals for worldwide exclusive rights to develop and … Continue reading →

Posted in Small Cap News | Leave a comment

Cardium Therapeutics Inc. (CXM) Regains Listing Compliance With NYSE Amex

Posted on January 6, 2012 by Mission IR

Cardium Therapeutics today reported that it had received notice from NYSE Regulation that the Company is now considered to have regained compliance with the listing requirements of the NYSE Amex LLC (formerly the American Stock Exchange). (Logo:  http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO) In the … Continue reading →

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

AdCare Health Systems, Inc. (ADK) Executes Purchase Agreement for Three Skilled Nursing Facilities in Arkansas

Posted on January 6, 2012 by MissionIR

AdCare Health Systems, Inc., a leading nursing home and assisted living company, today announced the company has signed a definitive purchase agreement for three skilled nursing facilities in Arkansas for $27.3 million. According to the press release, the acquisition is … Continue reading →

Posted in AdCare Health Systems Inc. ADK | Leave a comment

Expanding Range of Markets for FluoroPharma Medical, Inc. (FPMI)

Posted on January 5, 2012 by MissionIR

Fluoropharma Medical, developer of advanced medical diagnostic imaging products, sees an open-ended range of potential markets in its future, since many of the possibilities related to the advanced imaging technologies on which the company is focused have only begun to … Continue reading →

Posted in FluoroPharma Medical Inc. FPMI | Leave a comment

Albany Molecular Research Inc. (AMRI) and BioPontis Alliance LLC Enter Preferred Provider Agreement to Identify New Drug Opportunities

Posted on January 5, 2012 by MissionIR

Albany Molecular Research Inc., an Albany based global contract services and manufacturing organization, announced today that it will work with BioPontis Alliance, LLC in a preferred provider agreement to support BioPontis’ mission to bridge the gap between early stage research … Continue reading →

Posted in Small Cap News | Leave a comment

Targacept, Inc. (TRGT) Says AstraZeneca will Advance Alzheimer’s Drug

Posted on January 5, 2012 by MissionIR

Targacept, Inc. currently has five mid-to-late-stage drug candidates using innovative NNR Therapeutics for difficult to treat diseases and disorders of the nervous system. NNR Therapeutics selectively modulates the activity of specific neuronal nicotinic receptors, which are unique proteins that regulate … Continue reading →

Posted in Small Cap News | Leave a comment